TrialInvestigational new drugs2020

A phase I study of enfortumab vedotin in Japanese patients with locally advanced or metastatic urothelial carcinoma.

Shunji Takahashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.